FebriDx for C-reactive protein and myxovirus resistance protein A testing

  • Medtech innovation briefing
  • MIB224
  • Published: 
Download (PDF)

Regulatory information

FebriDx was CE marked as an in vitro diagnostic device in September 2014. This was updated in October 2018.